Researchers from Icahn School of Medicine at Mount Sinai Discuss Findings in COVID-19 (Deucravacitinib In Plaque Psoriasis: 2-year Safety and Efficacy Results From the Phase Iii Poetyk Trials)

Press/Media

Period12 Apr 2024

Media coverage

1

Media coverage

  • TitleResearchers from Icahn School of Medicine at Mount Sinai Discuss Findings in COVID-19 (Deucravacitinib In Plaque Psoriasis: 2-year Safety and Efficacy Results From the Phase Iii Poetyk Trials)
    Media name/outletNewsRx COVID-19 Daily
    Country/TerritoryUnited States
    Date12/04/24
    PersonsMark Lebwohl